Tango Therapeutics CFO Daniella Beckman departs with generous severance package

Filed May 8, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

• high

  CFO Daniella Beckman separated effective April 15, 2026, as determined by the Board. Her last day of employment was May 1, 2026. No reason for departure was disclosed in the filing.

  Item 5.02 verify on EDGAR →
• medium

  Beckman receives 12 months base salary severance paid over 12 months, plus 12 months of COBRA health insurance premium reimbursement under the separation agreement dated May 7, 2026.

  Item 5.02 verify on EDGAR →
• medium

  Company accelerated vesting on Beckman's stock options and restricted stock units equivalent to 24 months of additional service beyond her May 1 departure date, potentially diluting existing shareholders.

  Item 5.02 verify on EDGAR →